Federal court upholds drug privacy law
New York Times, November 19, 2008
A federal appeals court in Boston has dealt a setback to the pharmaceutical industry and companies that collect prescription data for use in drug marketing. The court upheld the right of states to prohibit the sale of doctor-specific prescription drug data that is widely used in pharmaceutical marketing. IMS Health and Verispan sued to block implementation of a New Hampshire law which prohibited the sale of computerized data showing which doctors were prescribing what drugs.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- How Chargemaster Data May Affect Hospital Revenue
- House Lawmakers Grill CMS Over Health Exchange Navigators
- ED Physicians Key to Half of Hospital Admissions
- Insurer's App Aims to Lower Healthcare Costs, Securely
- Don't Let Nurses Sink Your Bottom Line
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Building a Better Healthcare Board
- Fortunately, Angelina Jolie Isn't On Medicare
